Company · CIK 2100782

# Generate Biomedicines, Inc.

| CIK | [2100782](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0002100782) (SEC EDGAR) |
| --- | --- |
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | MA |
| Listed | GENB (Nasdaq) |
| First annual or quarterly report | 2026-05-07 |

## Offerings

 1 registration

| Registration | Label and status | First filed | Last event | Filings |
| --- | --- | --- | --- | --- |
| 333-293204 | IPO Final prospectus | 2026-02-04 | 2026-02-27 | 5 |

## Filings

 6

| Filed | Filing | Registration | Accession |
| --- | --- | --- | --- |
| 2026-02-27 | [424B4](https://www.sec.gov/Archives/edgar/data/2100782/000119312526083190/0001193125-26-083190-index.htm) Final prospectus | 333-293204 | 0001193125-26-083190 |
| 2026-02-26 | [EFFECT](https://www.sec.gov/Archives/edgar/data/2100782/999999999526000677/9999999995-26-000677-index.htm) Declared effective | 333-293204 | 9999999995-26-000677 |
| 2026-02-23 | [S-1/A](https://www.sec.gov/Archives/edgar/data/2100782/000119312526062362/0001193125-26-062362-index.htm) Amendment | 333-293204 | 0001193125-26-062362 |
| 2026-02-13 | [S-1/A](https://www.sec.gov/Archives/edgar/data/2100782/000119312526051761/0001193125-26-051761-index.htm) Amendment | 333-293204 | 0001193125-26-051761 |
| 2026-02-04 | [S-1](https://www.sec.gov/Archives/edgar/data/2100782/000119312526037799/0001193125-26-037799-index.htm) Registration filed | 333-293204 | 0001193125-26-037799 |
| 2025-12-23 | [DRS](https://www.sec.gov/Archives/edgar/data/2100782/000119312525330964/0001193125-25-330964-index.htm) Draft made public | 377-08875 | 0001193125-25-330964 |

[All filings of this company](https://equitycapital.markets/filings?cik=2100782) · [CSV](https://equitycapital.markets/filings.csv?cik=2100782)

---
Source page: https://equitycapital.markets/company/2100782 · Data: U.S. SEC EDGAR · CC BY 4.0